Aerosolized prostacyclin vs placebo
Respiratory effects: PaO2/FiO2 ratio up to 24 hours after initiation of therapy · people with ARDS
1 finding from 1 review
- Aerosolized prostacyclins for acute respiratory distress syndrome (ARDS) 2017 · Cochrane Headline outcomes onlyno estimate extracted1 study · 67 participantsVery low